Oaktree Acquisition Corp. III Life Sciences (OACC) Income from Continuing Operations (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Income from Continuing Operations readings, the most recent being 1394121.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 15.96% to 1394121.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 7024154.0 through Mar 2026, changed N/A year-over-year, with the annual reading at 7288824.0 for FY2025, 489.27% up from the prior year.
- Income from Continuing Operations hit 1394121.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from 1788948.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1966742.0 in Q3 2025 and bottomed at 1394121.0 in Q1 2026.